450 filings
Page 11 of 23
S-8
krzqjbvnovgfzj0 79v7
19 Feb 19
Registration of securities for employees
4:06pm
424B5
wy476vg79f
19 Feb 19
Prospectus supplement for primary offering
8:39am
8-K
n8pz48
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
yq7p3mco3x fa
14 Feb 19
Entry into a Material Definitive Agreement
12:00am
8-K
lk5uy4x
7 Jan 19
Other Events
7:01am
8-K
7fwd2kz 8fh7
4 Jan 19
Entry into a Material Definitive Agreement
4:23pm
8-K
ng60vhjwlc6 5pcc240n
28 Dec 18
Entry into a Material Definitive Agreement
2:39pm
8-K
h20bem
10 Dec 18
Other Events
2:07pm
8-K
q4kwlk1bcvwbzx hgc
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
mvwwwv93i7f4ya5zz
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am
8-K
lrg1ku3408ge 3v
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
yyz9cx hn2x59
17 Sep 18
Other Events
12:00am
8-K
se8 90tccagva2vjf0m
5 Sep 18
Recro Pharma to Present IV Meloxicam Data at PAINWeek® 2018
12:00am
8-K
w4pj8th2 64
4 Sep 18
Recro Pharma Provides Regulatory Update for IV Meloxicam
12:00am
8-K
a4wd ld90
7 Aug 18
Recro Pharma Reports Second Quarter 2018 Financial Results
7:05am
8-K
juev9tj7i64fdq
24 May 18
Recro Pharma Receives Complete Response Letter
7:05am